RNA-guided gene activation by CRISPR-Cas9–based transcription factorsPablo Pérez‐Piñera, Charles A. Gersbach, D. Dewran Koçak et al.|Nature Methods|2013Cited by 1.3k
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G. Ousterout, Charles A. Gersbach, Pratiksha I. Thakore et al.|Nature Communications|2015Cited by 456
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vectorAmi M. Kabadi, Charles A. Gersbach, David G. Ousterout et al.|Nucleic Acids Research|2014Cited by 388
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy PatientsDavid G. Ousterout, Charles A. Gersbach, Pablo Pérez‐Piñera et al.|Molecular Therapy|2013Cited by 176
Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger NucleasesDavid G. Ousterout, Charles A. Gersbach, Ami M. Kabadi et al.|Molecular Therapy|2014Cited by 111